Literature DB >> 28485411

Prostate cancer: PCA3 as a Grade Reclassification Predictor.

Annette Fenner.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28485411     DOI： 10.1038/nrurol.2017.70

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance.

Authors:  J J Tosoian; H D Patel; M Mamawala; P Landis; S Wolf; D J Elliott; J I Epstein; H B Carter; A E Ross; L J Sokoll; C P Pavlovich
Journal:  Prostate Cancer Prostatic Dis       Date:  2017-04-18       Impact factor: 5.554
  1 in total
  5 in total

1.  The long non-coding RNA PCA3: an update of its functions and clinical applications as a biomarker in prostate cancer.

Authors:  Ana Emília Goulart Lemos; Aline da Rocha Matos; Luciana Bueno Ferreira; Etel Rodrigues Pereira Gimba
Journal:  Oncotarget       Date:  2019-11-12

2.  Development and validation of a nomogram including lymphocyte-to-monocyte ratio for initial prostate biopsy: a double-center retrospective study.

Authors:  Zhong-Han Zhou; Feng Liu; Wen-Jie Wang; Xue Liu; Li-Jiang Sun; Yao Zhu; Ding-Wei Ye; Gui-Ming Zhang
Journal:  Asian J Androl       Date:  2021 Jan-Feb       Impact factor: 3.285

Review 3.  The Role and Significance of Bioumoral Markers in Prostate Cancer.

Authors:  Traian Constantin; Diana Alexandra Savu; Ștefana Bucur; Gabriel Predoiu; Maria Magdalena Constantin; Viorel Jinga
Journal:  Cancers (Basel)       Date:  2021-11-25       Impact factor: 6.639

4.  Liquid Biopsy to Detect DNA/RNA Based Markers of Small DNA Oncogenic Viruses for Prostate Cancer Diagnosis, Prognosis, and Prediction.

Authors:  Maurizio Provenzano; Abdou Kamal Allayeh
Journal:  Front Oncol       Date:  2020-07-08       Impact factor: 6.244

5.  Diagnostic performance of PCA3 and hK2 in combination with serum PSA for prostate cancer.

Authors:  Zujie Mao; Alin Ji; Kebing Yang; Wei He; Yingfang Hu; Qi Zhang; Dahong Zhang; Liping Xie
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.